Today: 28 February 2026
Subscribe
Browse Category

NASDAQ:ESTA 18 December 2025 - 2 February 2026

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs shares fell about 5% to $69.22 in early Friday trading, reversing part of a 10% gain earlier in the week. The drop came as broader U.S. markets rose on a softer December jobs report. Investors are watching for updates at the company’s Jan. 14 J.P. Morgan Healthcare Conference presentation and awaiting FDA review of its Motiva breast implants.
9 January 2026
·
Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference

Establishment Labs (ESTA) stock drops 5.5% — what to watch before Monday’s open and JPM conference

Establishment Labs shares fell 5.5% to $68.84 Friday, underperforming a flat Nasdaq. The company recently submitted its Motiva implants to the FDA for breast reconstruction approval. Management will present at the J.P. Morgan Healthcare Conference on Jan. 14. Establishment Labs posted a 2024 net loss of about $85 million on $166 million in revenue.
4 January 2026
··
Go toTop